Related Experiment Video
Updated: Sep 9, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of
Jihad A Mustapha1, Rita Jacob2, Larry E Miller3
1Lake City Cardiovascular Institute, Lake City, FL, USA.
Insights
Traditional clinical trial endpoints for chronic limb-threatening ischemia (CLTI) are insufficient. A modified clinically-driven target lesion revascularization (CD-TLR) definition is proposed to better reflect patient outcomes and modern CLTI management.
Area of Science:
- Vascular Surgery
- Clinical Trials
- Patient-Centered Outcomes
Background:
- Critical limb ischemia (CLI) has evolved into chronic limb-threatening ischemia (CLTI), necessitating updated clinical trial metrics.
- Traditional endpoints like hemodynamic indices and lesion patency fail to capture the complexity of CLTI or patient-centered outcomes.
- Current assessment methods may not adequately inform clinical decision-making for CLTI management.
Purpose of the Study:
- To explore the limitations of conventional endpoints used in CLTI clinical trials.
- To propose a modified definition of clinically-driven target lesion revascularization (CD-TLR) that incorporates inflow, target lesion, and outflow disease.
- To enhance the clinical relevance of trial results by aligning them with modern CLTI management strategies.
Main Methods:
- Review of existing literature on CLTI endpoints.
- Analysis of the shortcomings of traditional hemodynamic indices and lesion patency measures.
- Development of a modified CD-TLR definition focusing on comprehensive vascular assessment and patient-relevant outcomes.
Main Results:
- Conventional endpoints inadequately reflect CLTI complexity and patient-centered outcomes.
- A modified CD-TLR definition offers a more comprehensive assessment of vascular health.
- Prioritizing patient-relevant outcomes like limb salvage, wound healing, and function is crucial.
Conclusions:
- The evolution of CLI to CLTI demands a reevaluation of clinical trial endpoints.
- A modified CD-TLR definition better aligns with contemporary CLTI management.
- Emphasizing patient-centered outcomes over surrogate endpoints improves clinical decision-making and CLTI care.
Abstract:
The evolution from critical limb ischemia to chronic limb-threatening ischemia (CLTI) necessitates a reevaluation of clinical trial endpoints. Traditional measures like hemodynamic indices and lesion patency inadequately reflect CLTI complexity or patient-centered outcomes. This article explores the limitations of conventional endpoints and proposes a modified definition of clinically-driven target lesion (TL) revascularization (CD-TLR) that addresses inflow, TL, and outflow disease. By incorporating a more comprehensive assessment of vascular health and prioritizing patient-relevant outcomes, this modified CD-TLR definition may better reflect modern CLTI management strategies and improve clinical relevance of trial results in this challenging patient population.Clinical ImpactThe evolution from CLI to CLTI requires reassessing how we measure treatment success in clinical trials. This review identifies why traditional endpoints like hemodynamic indices, lesion patency, and CD-TLR may not adequately inform clinical decision-making. The importance of measuring outcomes that directly impact patient quality of life will help clinicians better evaluate and apply clinical trial results. An emphasis on limb salvage, wound healing, and functional outcomes, rather than surrogate endpoints alone, will lead to more informed treatment decisions and improved CLTI management strategies.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:02Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care